Elanco Animal Health (ELAN) Accounts Payables (2017 - 2026)
Elanco Animal Health's (ELAN) quarterly Accounts Payables came in at $427.0 million in Q2 2026, up 16.03% year-over-year from $368.0 million in Q2 2025, and up 14.78% quarter-over-quarter from $372.0 million in Q1 2026.
Analysis
Elanco Animal Health (ELAN) Accounts Payables (2017 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Accounts Payables across 10 years of filings, most recently posting $427.0 million for Q2 2026.
- In Q2 2026, Accounts Payables rose 16.03% year-over-year to $427.0 million; the TTM figure through Jun 2026 stood at $427.0 million (up 16.03% YoY), while the FY2025 annual figure was $368.0 million, up 24.32% from the prior year.
- Accounts Payables came in at $427.0 million for Q2 2026 at Elanco Animal Health, up from $372.0 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $427.0 million in Q2 2026 to a low of $259.0 million in Q3 2024.
- Average Accounts Payables over 5 years is $344.1 million, with a median of $353.0 million recorded in 2023.
- Year-over-year, Accounts Payables plunged 30.77% in 2023 and surged 35.91% in 2025.
- Over 5 years, Accounts Payables stood at $390.0 million in 2022, then sank by 30.77% to $270.0 million in 2023, then grew by 9.63% to $296.0 million in 2024, then climbed by 24.32% to $368.0 million in 2025, then increased by 16.03% to $427.0 million in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $427.0 million in Q2 2026, $372.0 million in Q1 2026, and $368.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.53 Bn | 40.34 Bn | 779.09 Mn | 129.10 Mn |
| 2 | Zoetis | 30.65 Bn | 28.97 Bn | 1.05 Bn | 452.00 Mn |
| 3 | Elanco Animal Health | 11.81 Bn | 11.28 Bn | 798.00 Mn | 427.00 Mn |
| 4 | Phibro Animal Health | 1.51 Bn | 1.42 Bn | 134.40 Mn | 127.31 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | 2.81 Mn |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - | 6.21 Mn |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 175.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 427.00 Mn |
| Mar 31, 2026 | 372.00 Mn |
| Dec 31, 2025 | 368.00 Mn |
| Sep 30, 2025 | 352.00 Mn |
| Jun 30, 2025 | 368.00 Mn |
| Mar 31, 2025 | 330.00 Mn |
| Dec 31, 2024 | 296.00 Mn |
| Sep 30, 2024 | 259.00 Mn |
| Jun 30, 2024 | 291.00 Mn |
| Mar 31, 2024 | 302.00 Mn |
| Dec 31, 2023 | 270.00 Mn |
| Sep 30, 2023 | 296.00 Mn |
| Jun 30, 2023 | 354.00 Mn |
| Mar 31, 2023 | 381.00 Mn |
| Dec 31, 2022 | 390.00 Mn |
| Sep 30, 2022 | 350.00 Mn |
| Jun 30, 2022 | 386.00 Mn |
| Mar 31, 2022 | 402.00 Mn |
| Dec 31, 2021 | 416.00 Mn |
| Sep 30, 2021 | 436.00 Mn |